EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MCR-3 and MCR-9 confer species-specific increases in colistin MICs

Anna Schumann, Martin Wiedmann

Microbiology · 19.08.2026 · 172 (8)

DOI: 10.1099/mic.0.001759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology, erschienen am 19.08.2026. Verfasst von Anna Schumann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Cornell University, Ithaca, NY, USA. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Escherichia coli Proteins, Drug Resistance, Bacterial. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Agriculture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the clinical treatment of infections with Enterobacteriaceae , the development of resistance to last-resort antimicrobials like colistin is of concern, as it limits treatment options. Since 2015, ten families of mobile colistin resistance ( mcr ) genes have been discovered; however, our understanding of MCR remains limited because (i) mcr-1 is the most studied variant, (ii) mcr variants are rarely compared and (iii) mcr variants are primarily studied in Escherichia coli , even though studies have shown that mcr variants can confer significantly different phenotypes and that lipid A (i.e. the target of colistin and mcr- modification) structurally differs between bacterial species. To fill this gap, we examined how mcr-3 and mcr-9 , as two less frequently studied mcr variants, impact the colistin resistance of laboratory-adapted and real-world (i.e. clinical or food) isolates of E. coli , Salmonella enterica and Klebsiella pneumoniae . We found that while mcr-3 consistently conferred colistin resistance to all tested strains, mcr-9 only conferred resistance to two strains. The fold-change in colistin minimum inhibitory concentrations was significantly impacted by both the bacterial species and the mcr variant but not by whether a strain was a laboratory-adapted or real-world isolate. Overall, our results suggest that while laboratory-adapted strains may provide a good estimate of mcr -mediated colistin resistance of real-world isolates, findings of mcr -mediated phenotypes in one bacterial species should not be extrapolated to another.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinAnti-Bacterial AgentsEscherichia coli ProteinsDrug Resistance, BacterialEscherichia coliKlebsiella pneumoniaeSalmonella entericaEnterobacteriaceaeBacterial ProteinsMicrobial Sensitivity TestsSpecies SpecificityHumansTransferases (Other Substituted Phosphate Groups)

Stichwörter der Autor:innen

Enterobacteriaceaecolistin resistancemcr

Substanzen

ColistinAnti-Bacterial AgentsEscherichia coli ProteinsMCR-3 protein, E coliBacterial ProteinsTransferases (Other Substituted Phosphate Groups)

Autor:innen und Institutionen

  • Department of Food Science, Cornell University, Ithaca, NY, USA.

Förderung

  • National Institute of Food and Agriculture

Zitieren

APA

Schumann, A., & Wiedmann, M. (2026). MCR-3 and MCR-9 confer species-specific increases in colistin MICs. Microbiology, 172(8). https://doi.org/10.1099/mic.0.001759

Vancouver

Schumann A, Wiedmann M. MCR-3 and MCR-9 confer species-specific increases in colistin MICs. Microbiology. 2026;172(8). doi:10.1099/mic.0.001759

BibTeX
@article{Schumann2026,
  author = {Schumann, Anna and Wiedmann, Martin},
  title = {MCR-3 and MCR-9 confer species-specific increases in colistin MICs},
  journal = {Microbiology},
  year = {2026},
  volume = {172},
  number = {8},
  doi = {10.1099/mic.0.001759}
}
Kostenlos starten →